{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:45Z","timestamp":1761513525287},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To investigate baseline characteristics associated with radiographic progression and the effect of disease activity, drug, switching, and withdrawal on radiographic progression in tumor necrosis factor (TNF) inhibitor-naive patients with rheumatoid arthritis (RA) followed for about 2 years after anti-TNF initiation in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>DANBIO-registered patients with RA who had available radiographs (anti-TNF initiation and \u223c2 yrs followup) were included. Radiographs were scored, blinded to chronology with the Sharp\/van der Heijde method and linked with DANBIO data. Baseline characteristics were investigated with univariate regression and significant variables included in a multivariable logistic regression analysis with \u00b1 radiographic progression [\u0394 total Sharp score (TSS) &gt; 0] as dependent variable. Effect of time-averaged C-reactive protein (CRP), 28-joint Disease Activity Score with CRP (DAS28-CRP), and treatment status at followup were investigated with univariate regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The study included 930 patients. They were 75% women, 79% positive for IgM-rheumatoid factor (IgM-RF), median age was 57 yrs (range 19\u201388), disease duration 9 yrs (1\u201359), DAS28-CRP 5.0 (1.4\u20137.8), TSS median 15 [3\u201345 interquartile range (IQR)] and mean 31 (SD 40). Patients started treatment with infliximab (59%), etanercept (18%), or adalimumab (23%). At followup (median 526 days, IQR 392\u2013735), 61% were treated with the initial anti-TNF, 29% had switched TNF inhibitor, and 10% had withdrawn. Twenty-seven percent of patients had progressed radiographically. \u0394TSS was median 0.0 [0.0\u20130.5 IQR\/mean 0.6 (SD 2.4)] units\/year. Higher TSS, older age, positive IgM-RF, and concomitant prednisolone at baseline were associated with radiographic progression. Time-averaged DAS28-CRP and time-averaged CRP, but not type of TNF inhibitor, were associated with radiographic progression. Patients who stopped\/switched during followup progressed more than patients who continued treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>High TSS, older age, IgM-RF positivity, and concomitant prednisolone were associated with radiographic progression during 2 years of followup of 930 anti-TNF\u2013treated patients with RA in clinical practice. High disease activity and switching\/stopping anti-TNF treatment were associated with radiographic progression.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.131299","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T07:42:40Z","timestamp":1412235760000},"page":"2352-2360","source":"Crossref","is-referenced-by-count":13,"title":["Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry"],"prefix":"10.3899","volume":"41","author":[{"given":"Lykke Midtb\u00f8ll","family":"\u00d8rnbjerg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille","family":"B\u00f8yesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Steen","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik","family":"Tarp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta Engling","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Espesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Graudal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Kollerup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte Vendelbo","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Rintek","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"B\u00f8hme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne R\u00f8dgaard","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2018112909334315000_41.12.2352.1","first-page":"35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909334315000_41.12.2352.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.2.122"},{"key":"2018112909334315000_41.12.2352.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432202"},{"key":"2018112909334315000_41.12.2352.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.20217"},{"key":"2018112909334315000_41.12.2352.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15640-7"},{"key":"2018112909334315000_41.12.2352.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22193"},{"key":"2018112909334315000_41.12.2352.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.27227"},{"key":"2018112909334315000_41.12.2352.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201319"},{"key":"2018112909334315000_41.12.2352.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel149"},{"key":"2018112909334315000_41.12.2352.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken002"},{"key":"2018112909334315000_41.12.2352.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.01.005"},{"key":"2018112909334315000_41.12.2352.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.121160"},{"key":"2018112909334315000_41.12.2352.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep155"},{"key":"2018112909334315000_41.12.2352.14","first-page":"1135","article-title":"Results from controlled clinical trials: how relevant for clinical practice?","volume":"30","author":"Kvien","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909334315000_41.12.2352.15","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N"},{"key":"2018112909334315000_41.12.2352.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.20350"},{"key":"2018112909334315000_41.12.2352.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.20982"},{"key":"2018112909334315000_41.12.2352.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.090019"},{"key":"2018112909334315000_41.12.2352.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.22143"},{"key":"2018112909334315000_41.12.2352.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq309"},{"key":"2018112909334315000_41.12.2352.21","first-page":"743","article-title":"How to read radiographs according to the Sharp\/van der Heijde method","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"2018112909334315000_41.12.2352.22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.018457"},{"key":"2018112909334315000_41.12.2352.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.10181"},{"key":"2018112909334315000_41.12.2352.24","doi-asserted-by":"publisher","DOI":"10.1191\/026921598672178340"},{"key":"2018112909334315000_41.12.2352.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6719.230"},{"key":"2018112909334315000_41.12.2352.26","unstructured":"The R Project for statistical computing. [Internet. Accessed August 27, 2014.] Available from: www.r-project.org\/"},{"key":"2018112909334315000_41.12.2352.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.21678"},{"key":"2018112909334315000_41.12.2352.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.10513"},{"key":"2018112909334315000_41.12.2352.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.7.732"},{"key":"2018112909334315000_41.12.2352.30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083675"},{"key":"2018112909334315000_41.12.2352.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.21570"},{"key":"2018112909334315000_41.12.2352.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.24463"},{"key":"2018112909334315000_41.12.2352.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088245"},{"key":"2018112909334315000_41.12.2352.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201391"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.131299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:45:26Z","timestamp":1543517126000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.131299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3899\/jrheum.131299"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.131299","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}